24小时热门版块排行榜    

查看: 2719  |  回复: 2

roro009

金虫 (小有名气)

[调剂信息] 美国Oklahoma Medical Research Foundation (OMRF)招收访问学者、访问学生

考研调剂招生信息

学校: -
专业: -
年级: 2018
招生人数: -
招生状态: 正在招生中
联系方式: ********* (为保护个人隐私,联系方式仅限APP查看)

补充内容

美国俄克拉荷马医学研究基金会(Oklahoma Medical Research Foundation)招收公派研究生和访问学者

          美国俄克拉荷马医学研究基金会Pengchun Yu博士实验室诚招公派研究生和访问学者。Pengchun Yu博士新近完成了其在美国耶鲁大学的博士后研究,加入俄克拉荷马医学研究基金会的心血管研究中心(Cardiovascular Biology Research Program)担任助理教授,其实验室于2018年11月正式开始运行。Yu博士的实验室致力于研究细胞代谢在血管发育、再生以及在相关心血管疾病中的作用。实验室综合使用小鼠遗传学、细胞生物学、生物化学、代谢组学以及转录组学的相关技术来回答领域内一系列的前沿问题。实验室条件优越,能够为加入的公派研究生和访问学者提供充足的研究资源和一流的科研训练。
          俄克拉荷马医学研究基金会(Oklahoma Medical Research Foundation),简称OMRF,成立于1946年,是一所独立的、非营利性的高水平生物医学研究机构。研究所主要致力于心血管疾病、癌症、自身免疫性疾病和老年痴呆等重大疾病的基础和转化医学研究。OMRF拥有超过700项美国和国际专利,并以部分专利技术为基础成立了11个生物技术公司。OMRF研究实力强劲、拥有完善的科研平台和支撑体系,包括Clinical Genomics Center、Human Phenotyping Core、Gnotobiotic Mouse Core、Quantitative Analysis Core等,能够为前沿科学研究的开展提供充分的技术支持和保障。OMRF位于俄克拉何马城(Oklahoma City)。俄克拉何马城是美国俄克拉荷马州的首府和第一大城市。在那里不仅可以体会到州府城市的大都会生活,如精致的饮食、顶级的艺术表演、NBA著名球队雷霆队的精彩比赛等,还可以感受到浓厚的西部牛仔风情。
           申请条件:(1)有资格申请或者已经获得国家留学基金委或者其他单位和机构的留学资助;(2)有细胞生物学、分子生物学、或者动物手术操作方面的相关经验;(3)学科背景没有限制。实验室将提供一流的科研条件和精心设计的前沿课题,还将帮助加入实验室的公派研究生和访问学者发表第一作者的研究论文。
           请将申请和简历发送至Pengchun-Yu@omrf.org
回复此楼

» 本帖附件资源列表

  • 欢迎监督和反馈:小木虫仅提供交流平台,不对该内容负责。
    本内容由用户自主发布,如果其内容涉及到知识产权问题,其责任在于用户本人,如对版权有异议,请联系邮箱:xiaomuchong@tal.com
  • 附件 1 : Recruitment_Visiting_Students_and_Scholars.pdf
  • 2018-08-20 14:36:59, 35.32 K

» 猜你喜欢

» 本主题相关商家推荐: (我也要在这里推广)

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

roro009

金虫 (小有名气)

Research Opportunities in Vascular Biology and Disease

The laboratory of Dr. Pengchun Yu in the Cardiovascular Biology Research Program at the Oklahoma Medical Research Foundation (OMRF) is seeking visiting scholars and students to investigate the metabolic regulation of vascular formation and its implications in vascular diseases.

The laboratory, which will formally open in November 2018, will focus on the interface between cellular metabolism and vascular biology. Dr. Yu has recently demonstrated that MYC/hexokinase 2 pathway-driven glucose metabolism in endothelial cells controls blood and lymphatic vessel formation (Yu et al., Nature, 2017). Research projects of the laboratory will be built upon this important finding to further study the crosstalk between metabolic programs and angiogenic signaling events and to understand the involvement of cellular metabolism in the pathogenesis of vascular diseases. Multidisciplinary strategies will be employed, ranging from novel genetically-modified mouse models to cutting-edge systems biology tools including metabolomics and single-cell transcriptome analysis.

OMRF is an independent, nonprofit biomedical research institute. The innovative basic and translational research at OMRF covers several critical areas such as cardiovascular disease, autoimmune disease, and cancer. The Cardiovascular Biology Research Program hosts 10 research groups studying various aspects of cardiovascular biology and provides a highly stimulating and collaborative environment. Moreover, OMRF offers state-of-the-art facilities and outstanding core technology laboratories including imaging, next-generation sequencing, and clinical genomics.

Ideal candidates will need to get funded by the China Scholarship Council or other funding agencies and have extensive experience in molecular and cellular biology or animal surgery. Prior experience in cardiovascular biology is not required. The successful applicants will receive first-rate research training and will be strongly encouraged and supported to publish first-author research papers in the laboratory.

Please send your application along with your curriculum vitae to Dr. Pengchun Yu at Pengchun-Yu@omrf.org.


Contact Information:
Pengchun Yu, Ph.D.
Assistant Member/Professor
Cardiovascular Biology Research Program
Oklahoma Medical Research Foundation
825NE 13th St., Oklahoma City, OK 73104
2楼2018-08-20 14:45:58
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

周奎6029

木虫 (正式写手)

引用回帖:
2楼: Originally posted by roro009 at 2018-08-20 14:45:58
Research Opportunities in Vascular Biology and Disease

The laboratory of Dr. Pengchun Yu in the Cardiovascular Biology Research Program at the Oklahoma Medical Research Foundation (OMRF) is seekin ...

Oklahoma Medical Research Foundation这个机构隶属于哪里?招生物3D打印方向的访问学者不?
3楼2018-08-23 08:26:00
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 roro009 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] 面上没中,邀请各位路过的虫友分析一下分数 +3 jackleilei 2026-09-03 3/150 2026-09-03 19:13 by god_tian
[考研] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 YLHlRHNwYkce 2026-09-02 7/350 2026-09-03 18:50 by jyNB2vrbdUpR
[硕博家园] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +4 YLHlRHNwYkce 2026-09-02 8/400 2026-09-03 18:50 by jyNB2vrbdUpR
[找工作] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 ero8OE6tv9cu 2026-09-02 8/400 2026-09-03 16:38 by T0rGB46095mJ
[基金申请] 国社科又开始会评了,不知道这次命运如何 +10 雨打竹帘 2026-08-30 14/700 2026-09-03 13:17 by qsd10086
[教师之家] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 YLHlRHNwYkce 2026-09-02 8/400 2026-09-03 12:03 by T0rGB46095mJ
[基金申请] 麻烦专家们看看评委们的意见(F口面上) +8 gdd2018 2026-08-28 13/650 2026-09-03 06:22 by 羽毛枫f
[公派出国] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +3 ero8OE6tv9cu 2026-09-02 4/200 2026-09-03 03:14 by rM1TE0WVDIIY
[基金申请] 要骂人了,新模版改版就是要淡化问题凝练这种虚的东西,结果有个评委还在说凝练得不够 +9 瞬息宇宙 2026-08-31 17/850 2026-09-02 14:04 by anjeeshine
[基金申请] 学科评审组评审是指会评吗? +5 瞬息宇宙 2026-08-31 5/250 2026-09-02 10:13 by 雨冰共舞
[基金申请] 面上函评意见出来了,像什么等级? 20+4 Tsingking1 2026-08-27 17/850 2026-09-01 19:51 by 超级无敌华子
[论文投稿] 小白求助 投论文要求的highlights应该如何写 5+3 l1963982152 2026-08-29 4/200 2026-09-01 09:04 by 北京莱茵编辑
[基金申请] 面上意见出来了 +12 黄鸟于飞Chao 2026-08-29 23/1150 2026-08-31 18:57 by 黄鸟于飞Chao
[基金申请] 能否申诉? +7 echo8914667 2026-08-30 8/400 2026-08-31 17:00 by yihongxu
[基金申请] 中青基了要发朋友圈吗? +7 349506619 2026-08-28 7/350 2026-08-31 13:39 by 冼亮淀粉酶
[基金申请] 29号明天会评吗 +4 笨笨唐 2026-08-28 4/200 2026-08-31 09:30 by huixian257
[基金申请] 为什么到现在没收到通知? +5 tannykie 2026-08-29 5/250 2026-08-30 21:05 by purplejack
[考博] 找导师 +6 yuanjiabao 2026-08-29 7/350 2026-08-30 14:40 by 生科新手
[基金申请] 我就是申请一个面上项目而已,这评审意见是按照杰青的条件评的吧? +6 gouxfjh 2026-08-28 11/550 2026-08-30 07:57 by gouxfjh
[基金申请] 国自然评审意见 +13 wangmingqi 2026-08-28 19/950 2026-08-29 10:22 by Poppy1104
信息提示
请填处理意见